|
EP1366030A2
(en)
|
2000-07-06 |
2003-12-03 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
|
CA2446351A1
(en)
|
2001-05-04 |
2002-11-14 |
Tularik Inc. |
Fused heterocyclic compounds
|
|
US6809104B2
(en)
|
2001-05-04 |
2004-10-26 |
Tularik Inc. |
Fused heterocyclic compounds
|
|
CN1703401A
(zh)
*
|
2001-05-22 |
2005-11-30 |
神经原公司 |
黑色素浓集激素受体的配体:取代的1－苄基－4－芳基哌嗪类似物
|
|
JP2005519876A
(ja)
|
2001-11-27 |
2005-07-07 |
メルク エンド カムパニー インコーポレーテッド |
２−アミノキノリン化合物
|
|
US7160879B2
(en)
*
|
2002-01-10 |
2007-01-09 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
|
|
WO2003059289A2
(en)
|
2002-01-10 |
2003-07-24 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
DE10238865A1
(de)
*
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
EP1562943A1
(en)
*
|
2002-11-06 |
2005-08-17 |
Amgen Inc. |
Fused heterocyclic compounds
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
AU2004209505B2
(en)
*
|
2003-02-10 |
2009-07-23 |
Banyu Pharmaceutical Co., Ltd. |
Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
|
|
WO2004072018A1
(ja)
*
|
2003-02-12 |
2004-08-26 |
Takeda Pharmaceutical Company Limited |
アミン誘導体
|
|
AU2004266228A1
(en)
*
|
2003-08-13 |
2005-03-03 |
Amgen, Inc. |
Melanin concentrating hormone receptor antagonists
|
|
MXPA06001636A
(es)
*
|
2003-08-13 |
2006-04-28 |
Amgen Inc |
Antagonista del receptor de la hormona concentradora de melanina.
|
|
JP4765627B2
(ja)
|
2003-09-22 |
2011-09-07 |
Ｍｓｄ株式会社 |
新規ピペリジン誘導体
|
|
KR20060060047A
(ko)
*
|
2003-10-01 |
2006-06-02 |
더 프록터 앤드 갬블 캄파니 |
멜라닌 농축 호르몬 길항제
|
|
US20060247239A1
(en)
*
|
2003-10-01 |
2006-11-02 |
Hu Xiufeng E |
Melanin concentrating hormone antagonists
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
WO2005110989A1
(en)
*
|
2004-04-07 |
2005-11-24 |
Neurogen Corporation |
Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
|
|
US7253168B2
(en)
|
2004-04-07 |
2007-08-07 |
Neurogen Corporation |
Substituted 1-benzyl-4-substituted piperazine analogues
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7524862B2
(en)
|
2004-04-14 |
2009-04-28 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
TW200609219A
(en)
*
|
2004-06-17 |
2006-03-16 |
Neurogen Corp |
Aryl-substituted piperazine derivatives
|
|
US7063034B2
(en)
*
|
2004-08-10 |
2006-06-20 |
Watermark Paddlesports, Inc. |
Spray skirt for watercraft
|
|
CA2577060A1
(en)
|
2004-08-13 |
2006-02-23 |
Amgen Inc. |
Substituted benzofused heterocycles
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
BRPI0518241A
(pt)
|
2004-11-01 |
2008-04-22 |
Amylin Pharmaceuticals Inc |
métodos para tratar obesidade e doenças e distúrbios relacionados à obesidade
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
RU2417985C2
(ru)
|
2005-05-30 |
2011-05-10 |
Баниу Фармасьютикал Ко., Лтд. |
Новые производные пиперидина
|
|
MX2007014464A
(es)
*
|
2005-05-31 |
2008-02-07 |
Astrazeneca Ab |
Antagonistas novedosos de mchr1 y sus usos para tratamiento de padecimientos y trastornos mediados por mchr1.
|
|
WO2007018248A1
(ja)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
ピリドン化合物
|
|
EP2330125A3
(en)
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
CA2619770A1
(en)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
|
BRPI0616463A2
(pt)
|
2005-09-29 |
2011-06-21 |
Merck & Co Inc |
composto, composição farmacêutica, e, uso de um composto
|
|
ES2322965T3
(es)
|
2005-09-30 |
2009-07-02 |
F. Hoffmann-La Roche Ag |
Derivados de indano como antagonistas de receptores de mch.
|
|
US20080255084A1
(en)
|
2005-10-21 |
2008-10-16 |
Randy Lee Webb |
Combination of Organic Compounds
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
US8158791B2
(en)
|
2005-11-10 |
2012-04-17 |
Msd K.K. |
Aza-substituted spiro derivatives
|
|
US7671221B2
(en)
*
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
CA2856037C
(en)
*
|
2005-12-28 |
2017-03-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
WO2007124045A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Ampla Pharmaceuticals, Inc. |
Piperidine and piperazine compounds for use in the treatment of obesity, eating disorders and sexual dysfunction by potentiation of mc4 receptor activity
|
|
EP2698157B1
(en)
|
2006-09-22 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
US20090247560A1
(en)
|
2006-09-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
CA2674237C
(en)
|
2006-12-28 |
2015-11-24 |
Rigel Pharmaceuticals, Inc. |
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
|
|
JP5319518B2
(ja)
|
2007-04-02 |
2013-10-16 |
Ｍｓｄ株式会社 |
インドールジオン誘導体
|
|
JP5514716B2
(ja)
*
|
2007-05-11 |
2014-06-04 |
コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー |
アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8034782B2
(en)
|
2008-07-16 |
2011-10-11 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
|
US20110015198A1
(en)
|
2008-03-28 |
2011-01-20 |
Banyu Pharmaceutical Co., Inc. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CA2727914A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diaryl ketoxime derivative technical field
|
|
AU2009277736A1
(en)
|
2008-07-30 |
2010-02-04 |
Banyu Pharmaceutical Co., Ltd. |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
MX2011004551A
(es)
|
2008-10-30 |
2011-05-25 |
Merck Sharp & Dohme |
Antagonistas del receptor de orexina de isonicotinamida.
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
PH12013501686A1
(en)
|
2011-02-25 |
2017-10-25 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
CA2880901A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
CN105764916B
(zh)
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2021109549A
(ru)
|
2014-08-29 |
2021-05-13 |
Тес Фарма С.Р.Л. |
ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
MX2021005904A
(es)
|
2018-11-20 |
2021-09-08 |
Tes Pharma S R L |
Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa.
|
|
EP3924058A1
(en)
|
2019-02-13 |
2021-12-22 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
|
US12331018B2
(en)
|
2019-02-13 |
2025-06-17 |
Merck Sharp & Dohme Llc |
Pyrrolidine orexin receptor agonists
|
|
WO2021026047A1
(en)
|
2019-08-08 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
GEAP202416395A
(en)
|
2020-08-18 |
2024-02-12 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|